MedTrace Logo

Care Expansion Across Remote Environments - Sub-Study of the SELF-GYN1 Trial

NCT05509322 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-04-12

No results posted yet for this study

Summary

This real-world, interventional sub-study will evaluate the impact of potential payer subsidies for Turtle Health at-home consults on subsequent interactions with the healthcare system within select sub-populations of interest.

Conditions

  • Fertility Risk

Interventions

OTHER

Subsidy for fertility consult

Some participants will receive a subsidy when they purchase the fertility consult.

OTHER

Invitation to purchase fertility consult

Some participants will receive an invitation from their health center to purchase an at-home fertility consult.

Sponsors & Collaborators

  • Turtle Health, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2023-04-10
Completion
2023-04-10
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05509322 on ClinicalTrials.gov